News | January 17, 2024
Parexel collaborates with Japanese Foundation for cancer research
Collaboration streamlines patient access to oncology clinical trials
Collaboration streamlines patient access to oncology clinical trials
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Arco Lab now holds a 50% stake in Neviton
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
Sirius JV will be owned 51% by Sirius and 49% by Adani
Subscribe To Our Newsletter & Stay Updated
